In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed at $31.08 down -7.20% from its previous closing price of $33.49. In other words, the price has decreased by -$7.20 from its previous closing price. On the day, 1.16 million shares were traded. SUPN stock price reached its highest trading level at $32.71 during the session, while it also had its lowest trading level at $29.5.
Ratios:
For a deeper understanding of Supernus Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.09. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on September 11, 2024, Downgraded its rating to Neutral and sets its target price to $36 from $41 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 02 ’24 when TAMI TILLOTSON MARTIN bought 4,000 shares for $29.02 per share.
TAMI TILLOTSON MARTIN bought 3,100 shares of SUPN for $90,856 on Aug 01 ’24. On Jul 31 ’24, another insider, TAMI TILLOTSON MARTIN, who serves as the Former Officer of the company, bought 5,000 shares for $30.13 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1845480704 and an Enterprise Value of 1405465472. As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 351.98, and their Forward P/E ratio for the next fiscal year is 17.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 208.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 2.23 whereas that against EBITDA is 11.187.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $35.44, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is -0.43%, while the 200-Day Moving Average is calculated to be 4.92%.
Shares Statistics:
For the past three months, SUPN has traded an average of 521.95K shares per day and 363190 over the past ten days. A total of 54.72M shares are outstanding, with a floating share count of 52.76M. Insiders hold about 4.26% of the company’s shares, while institutions hold 107.75% stake in the company. Shares short for SUPN as of 1723680000 were 6555111 with a Short Ratio of 12.56, compared to 1721001600 on 6310884. Therefore, it implies a Short% of Shares Outstanding of 6555111 and a Short% of Float of 18.120001.
